ALTEOGEN Statistics

Total Valuation

ALTEOGEN has a market cap or net worth of KRW 18.47 trillion. The enterprise value is 18.40 trillion.

Market Cap	18.47T
Enterprise Value	18.40T

Important Dates

The last earnings date was Monday, November 11, 2024.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

ALTEOGEN has 53.30 million shares outstanding. The number of shares has increased by 0.14% in one year.

Current Share Class	n/a
Shares Outstanding	53.30M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	26.49%
Owned by Institutions (%)	9.93%
Float	39.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	200.03
PB Ratio	99.11
P/TBV Ratio	n/a
P/FCF Ratio	1,261.48
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14,349.67
EV / Sales	202.71
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	1,257.14

Financial Position

The company has a current ratio of 9.28, with a Debt / Equity ratio of 0.04.

Current Ratio	9.28
Quick Ratio	8.76
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	0.80
Interest Coverage	-10.49

Financial Efficiency

Return on equity (ROE) is -1.39% and return on invested capital (ROIC) is -1.89%.

Return on Equity (ROE)	-1.39%
Return on Assets (ROA)	-1.76%
Return on Capital (ROIC)	-1.89%
Revenue Per Employee	626.12M
Profits Per Employee	-8.84M
Employee Count	145
Asset Turnover	0.31
Inventory Turnover	57.57

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +374.96% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+374.96%
50-Day Moving Average	368,360.00
200-Day Moving Average	252,812.00
Relative Strength Index (RSI)	35.40
Average Volume (20 Days)	960,905

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ALTEOGEN had revenue of KRW 90.79 billion and -1.28 billion in losses. Loss per share was -24.58.

Revenue	90.79B
Gross Profit	34.48B
Operating Income	-8.13B
Pretax Income	-3.60B
Net Income	-1.28B
EBITDA	-5.07B
EBIT	-8.13B
Loss Per Share	-24.58

Full Income Statement

Balance Sheet

The company has 163.90 billion in cash and 11.75 billion in debt, giving a net cash position of 152.15 billion or 2,854.80 per share.

Cash & Cash Equivalents	163.90B
Total Debt	11.75B
Net Cash	152.15B
Net Cash Per Share	2,854.80
Equity (Book Value)	274.34B
Book Value Per Share	3,496.13
Working Capital	161.21B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.05 billion and capital expenditures -1.42 billion, giving a free cash flow of 14.64 billion.

Operating Cash Flow	16.05B
Capital Expenditures	-1.42B
Free Cash Flow	14.64B
FCF Per Share	274.68

Full Cash Flow Statement

Margins

Gross margin is 37.98%, with operating and profit margins of -8.96% and -1.41%.

Gross Margin	37.98%
Operating Margin	-8.96%
Pretax Margin	-3.96%
Profit Margin	-1.41%
EBITDA Margin	-5.59%
EBIT Margin	-8.96%
FCF Margin	16.12%

Dividends & Yields

ALTEOGEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.14%
Shareholder Yield	-0.14%
Earnings Yield	-0.01%
FCF Yield	0.08%

Stock Splits

The last stock split was on October 25, 2022. It was a forward split with a ratio of 1.2.

Last Split Date	Oct 25, 2022
Split Type	Forward
Split Ratio	1.2

Scores

ALTEOGEN has an Altman Z-Score of 111.99.

Altman Z-Score	111.99
Piotroski F-Score	n/a